OTCMKTS:STXS - Stereotaxis Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.3575 +0.01 (+0.43 %) (As of 05/21/2019 02:40 PM ET)Previous Close$2.35Today's Range$2.30 - $2.5052-Week Range$0.6310 - $2.45Volume181,679 shsAverage Volume64,870 shsMarket Capitalization$139.85 millionP/E RatioN/ADividend YieldN/ABeta2.1 ProfileChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic system that enables physicians to complete interventional procedures by providing image guided delivery of catheters and guide wires through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri. Receive STXS News and Ratings via Email Sign-up to receive the latest news and ratings for STXS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:STXS Previous SymbolNASDAQ:STXS CUSIPN/A CIK1289340 Webwww.stereotaxis.com Phone314-678-6100Debt Debt-to-Equity RatioN/A Current Ratio1.31 Quick Ratio1.65Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$29.35 million Price / Sales4.76 Cash Flow$0.0131 per share Price / Cash Flow179.46 Book Value($0.01) per share Price / Book-235.75Profitability EPS (Most Recent Fiscal Year)N/A Net Income$120,000.00 Net Margins-11.71% Return on Equity-329.68% Return on Assets-17.09%Miscellaneous Employees119 Outstanding Shares59,321,000Market Cap$139.85 million Next Earnings Date8/6/2019 (Estimated) OptionableNot Optionable Stereotaxis (OTCMKTS:STXS) Frequently Asked Questions What is Stereotaxis' stock symbol? Stereotaxis trades on the OTCMKTS under the ticker symbol "STXS." How were Stereotaxis' earnings last quarter? Stereotaxis Inc (OTCMKTS:STXS) announced its earnings results on Thursday, May, 9th. The medical equipment provider reported ($0.04) EPS for the quarter. The medical equipment provider had revenue of $7.01 million for the quarter. Stereotaxis had a negative return on equity of 329.68% and a negative net margin of 11.71%. View Stereotaxis' Earnings History. When is Stereotaxis' next earnings date? Stereotaxis is scheduled to release their next quarterly earnings announcement on Tuesday, August 6th 2019. View Earnings Estimates for Stereotaxis. Has Stereotaxis been receiving favorable news coverage? Press coverage about STXS stock has been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Stereotaxis earned a news impact score of 1.3 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the near future. Who are some of Stereotaxis' key competitors? Some companies that are related to Stereotaxis include BioLife Solutions (BLFS), Semler Scientific (SMLR), Rockwell Medical (RMTI), Zynex (ZYXI), Cutera (CUTR), BioSig Technologies (BSGM), Fonar (FONR), Second Sight Medical Products (EYES), Edap Tms (EDAP), electroCore (ECOR), IRIDEX (IRIX), Soleno Therapeutics (SLNO), Helius Medical Technologies (HSDT), Viveve Medical (VIVE) and Precision Optics (PEYE). What other stocks do shareholders of Stereotaxis own? Based on aggregate information from My MarketBeat watchlists, some companies that other Stereotaxis investors own include XOMA (XOMA), Check Cap (CHEK), AVEO Pharmaceuticals (AVEO), Denbury Resources (DNR), Ascent Solar Technologies (ASTI), CDTi Advanced Materials (CDTI), Acer Therapeutics (ACER), Alnylam Pharmaceuticals (ALNY), Conatus Pharmaceuticals (CNAT) and MannKind (MNKD). Who are Stereotaxis' key executives? Stereotaxis' management team includes the folowing people: Mr. David Leo Fischel C.F.A., CFA, CPA, CEO & Chairman (Age 32)Mr. Martin C. Stammer, Chief Financial Officer (Age 39)Mr. Kevin M. Barry, Chief Legal Officer, Corp. Sec. & Chief Compliance OfficerDr. Gery Tomassoni M.D., FHRS, Chief Medical OfficerDr. J. David Burkhardt, Chief Devel. Advisor How do I buy shares of Stereotaxis? Shares of STXS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Stereotaxis' stock price today? One share of STXS stock can currently be purchased for approximately $2.3575. How big of a company is Stereotaxis? Stereotaxis has a market capitalization of $139.85 million and generates $29.35 million in revenue each year. Stereotaxis employs 119 workers across the globe. What is Stereotaxis' official website? The official website for Stereotaxis is http://www.stereotaxis.com. How can I contact Stereotaxis? Stereotaxis' mailing address is 4320 FOREST PARK AVENUE SUITE 100, ST.LOUIS MO, 63108. The medical equipment provider can be reached via phone at 314-678-6100 or via email at [email protected] MarketBeat Community Rating for Stereotaxis (OTCMKTS STXS)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 88 (Vote Outperform)Underperform Votes: 106 (Vote Underperform)Total Votes: 194MarketBeat's community ratings are surveys of what our community members think about Stereotaxis and other stocks. Vote "Outperform" if you believe STXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STXS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Average Daily Trade Volume - What You Need to Know Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.